University of Michigan ALK Positive Webinar
Amy Moore, PhD, LUNGevity's Vice President, Global Engagement and Patient Partnerships, conducts this webinar on ALK-positive lung cancer.
Amy Moore, PhD, LUNGevity's Vice President, Global Engagement and Patient Partnerships, conducts this webinar on ALK-positive lung cancer.
Historically, surgery has been the most effective treatment for patients with early-stage non-small cell lung cancer (NSCLC). While technological improvements, such as the development of minimally invasive techniques (such as video-assisted thoracoscopic surgery or VATS), have made surgeries safer for patients, the ability to cure early-stage NSCLC patients hasn’t improved significantly in recent decades.